|
Fredun Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
475.40 Cr.
|
P/BV
|
3.63
|
Book Value (Rs.)
|
277.17
|
|
52 Week High/Low (Rs.)
|
1020/635
|
FV/ML
|
10/1
|
P/E(X)
|
22.85
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
44.07
|
Div Yield (%)
|
0.07
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 451.71 | 346.58 | 274.34 | 221.74 | 131.48 |
| Other Operating Revenues | 0.00 | 1.58 | 0.33 | 2.72 | 2.41 |
| Total Operating Revenues | 451.71 | 348.16 | 274.68 | 224.46 | 133.89 |
| | | | | | |
| Other Income | 4.56 | 0.92 | 1.82 | 1.63 | 1.40 |
| Total Revenue | 456.27 | 349.07 | 276.50 | 226.09 | 135.29 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 323.98 | 283.76 | 246.40 | 177.11 | 101.08 |
| Operating And Direct Expenses | 0.00 | 13.62 | 9.58 | 7.15 | 4.77 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 6.05 | -22.44 | -37.72 | -0.01 | 1.17 |
| Employee Benefit Expenses | 22.23 | 12.50 | 11.53 | 10.66 | 8.66 |
| Finance Costs | 22.38 | 13.65 | 9.28 | 4.67 | 4.16 |
| Depreciation And Amortisation Expenses | 4.45 | 3.80 | 2.81 | 2.16 | 2.00 |
| Other Expenses | 48.91 | 22.73 | 17.10 | 15.75 | 9.08 |
| Total Expenses | 428.00 | 327.62 | 258.99 | 217.49 | 130.92 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 28.27 | 21.45 | 17.51 | 8.60 | 4.37 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -1.16 |
| Profit/Loss Before Tax | 28.27 | 21.45 | 17.51 | 8.60 | 3.21 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 7.46 | 5.54 | 4.29 | 2.21 | 0.76 |
| Deferred Tax | 0.00 | 0.29 | 2.41 | 0.05 | 0.44 |
| Total Tax Expenses | 7.46 | 5.83 | 6.70 | 2.26 | 1.19 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 20.81 | 15.62 | 10.81 | 6.34 | 2.01 |
| | | | | | |
| Profit/Loss From Continuing Operations | 20.81 | 15.62 | 10.81 | 6.34 | 2.01 |
| | | | | | |
| Profit/Loss For The Period | 20.81 | 15.62 | 10.81 | 6.34 | 2.01 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 44.83 | 33.66 | 24.13 | 11.28 | 5.05 |
| Diluted EPS (Rs.) | 44.83 | 33.32 | 22.93 | 11.28 | 5.05 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.33 | 0.31 | 0.31 | 0.27 |
| Equity Dividend Rate (%) | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 |
